SUPERSTRING CAPITAL MANAGEMENT LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001931118

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 37 positions · Total reported value $151.24M · Top-10 concentration 64.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.1% · 8 new · 9 cut · 11 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.6% · vs SPY +11.8% · Prev Value $139.97M — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2024 13F filing, SUPERSTRING CAPITAL MANAGEMENT LP disclosed 37 equity positions with a combined reported value of $151.24M. The filing implies a focused portfolio: its ten largest positions account for 64.5% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were CYTK ($19.55M), NKTX ($12.86M), ETNB ($10.96M). By sector, the heaviest allocations are Health Care 74.0%, Information Technology 0.1%. Versus the prior quarter, allocation shifted toward Health Care (+9.0pp) and away from Information Technology (-0.6pp), Industrials (-1.4pp).

Versus the prior quarter, SUPERSTRING CAPITAL MANAGEMENT LP opened 8 new positions, trimmed 9 and fully exited 11, a turnover rate of 65.1% of positions. The portfolio's overlap with the prior quarter was 43% of names.

The largest new positions opened in Q1 2024 were CABA ($4.96M), AVTE ($3.26M), APGE ($2.98M).

Of the 11 positions fully exited versus the prior quarter, the largest were IMGN ($17.73M), PTGX ($8.69M), IMVT ($8.58M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • CABA CABALETTA BIO INC · $4.96M
  • AVTE AEROVATE THERAPEUTICS INC · $3.26M
  • APGE APOGEE THERAPEUTICS INC · $2.98M
  • DYN DYNE THERAPEUTICS INC · $2.83M
  • PRAX PRAXIS PRECISION MEDICINES I · $2.45M
  • PYXS PYXIS ONCOLOGY INC · $2.10M
  • ASND ASCENDIS PHARMA A/S · $1.93M
  • PEPG PEPGEN INC · $1.68M

Fully Exited (vs previous quarter)

  • IMGN IMMUNOGEN INC · prev qtr: $17.73M
  • PTGX PROTAGONIST THERAPEUTICS INC · prev qtr: $8.69M
  • IMVT IMMUNOVANT INC · prev qtr: $8.58M · history
  • NBIX NEUROCRINE BIOSCIENCES INC · prev qtr: $3.87M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $3.40M
  • SLRN ACELYRIN INC · prev qtr: $2.66M
  • KRYS KRYSTAL BIOTECH INC · prev qtr: $2.00M
  • QTRX QUANTERIX CORP · prev qtr: $1.96M

Insider Transactions (Form 4)

Latest SUPERSTRING CAPITAL MANAGEMENT LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Superstring Capital Management, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 32 positions worth $158.38M in total. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118766 (status: Approved), registered 2020-05-20
  • Regulatory AUM (Form ADV): $339.50M as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: superstringcap.com

Portfolio Structure

  • 32 positions · $158.38M reported value (Q2 2026)
  • Top 10 holdings = 63.8% of reported value
  • Largest position: COGT (COGENT BIOSCIENCES INC) at 8.4%
  • Average position size: $4.95M

Sector Tilt

  • Health Care 99.8%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 8 new, 12 added, 9 reduced, 11 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 74.0%
Other 25.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 278.92K $19.55M 12.93%
12.93%
Add
2 1.19M $12.86M 8.50%
8.50%
Add
3 941.29K $10.96M 7.25%
7.25%
Reduce
4 353.51K $10.93M 7.23%
7.23%
Add
5 2.07M $10.28M 6.80%
6.80%
Add
6 217.07K $9.53M 6.30%
6.30%
Reduce
7 920.48K $6.76M 4.47%
4.47%
Add
8 349.68K $5.78M 3.82%
3.82%
Reduce
9 531.02K $5.60M 3.70%
3.70%
Add
10 120.90K $5.24M 3.46%
3.46%
Reduce
11 565.55K $5.11M 3.38%
3.38%
Add
12 290.80K $4.96M 3.28%
3.28%
New
13 288.27K $4.32M 2.86%
2.86%
Add
14 259.38K $4.17M 2.76%
2.76%
Add
15 110.26K $3.26M 2.16%
2.16%
New
16 44.87K $2.98M 1.97%
1.97%
New
17 36.61K $2.92M 1.93%
1.93%
Add
18 99.82K $2.83M 1.87%
1.87%
New
19 40.12K $2.45M 1.62%
1.62%
New
20 521.25K $2.33M 1.54%
1.54%
Add
21 33.83K $2.24M 1.48%
1.48%
Reduce
22 493.76K $2.10M 1.39%
1.39%
New
23 12.75K $1.93M 1.27%
1.27%
New
24 114.39K $1.68M 1.11%
1.11%
New
25 69.97K $1.60M 1.06%
1.06%
New
26 1.23M $1.55M 1.03%
1.03%
New
27 679.40K $1.48M 0.98%
0.98%
New
28 155.73K $1.12M 0.74%
0.74%
New
29 37.03K $945.03K 0.62%
0.62%
New
30 145.28K $903.67K 0.60%
0.60%
New
31 112.74K $863.58K 0.57%
0.57%
Reduce
32 98.69K $494.44K 0.33%
0.33%
New
33 32.02K $379.82K 0.25%
0.25%
New
34 9.04K $358.27K 0.24%
0.24%
New
35 440.23K $345.97K 0.23%
0.23%
Add
36 307.92K $215.54K 0.14%
0.14%
Hold
37 182.74K $199.19K 0.13%
0.13%
Reduce

FAQ

What did SUPERSTRING CAPITAL MANAGEMENT LP buy in 2024-Q1?

In its 2024-Q1 13F filing, SUPERSTRING CAPITAL MANAGEMENT LP reported 37 equity positions worth $151.24M in aggregate; its largest disclosed positions were CYTK ($19.55M), NKTX ($12.86M), ETNB ($10.96M).

How large is SUPERSTRING CAPITAL MANAGEMENT LP's portfolio?

SUPERSTRING CAPITAL MANAGEMENT LP reported $151.24M of long equity holdings across 37 positions as of 2024-Q1. Top-10 holdings account for 64.5% of reported value.

What is SUPERSTRING CAPITAL MANAGEMENT LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/superstring-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →